Belmont Global Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Belmont Global Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-80,000	Closed	-$359K	–	86
2016 Q2	$359K	Buy	+80,000	New	+$300K	0.34%	52
2014 Q4	–	Sell	-10,000	Closed	-$45K	–	142
2014 Q3	$45K	Sell	10,000 -10,000	-50%	-$52.9K	0.04%	120
2014 Q2	$117K	Sell	20,000 -154,297	-89%	-$866K	0.08%	125
2014 Q1	$1.16M	Sell	174,297 -703	-0.4%	-$4.88K	0.97%	29
2013 Q4	$1.01M	Buy	+175,000	New	+$902K	0.82%	35

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Belmont Global Advisors's CCXI Position: Q3 2016 in Review

Belmont Global Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q3 2016, closing a stake of 80,000 shares — an estimated $359K sold.

Belmont Global Advisors first reported a position in CCXI in Q4 2013 and held it in 5 quarters. The position peaked at $1.16M in Q1 2014. 72 funds tracked by Wall St. Rank hold CCXI as of Q3 2016.

Belmont Global Advisors reported no remaining ChemoCentryx, Inc. position as of Q3 2016 after selling out during the quarter.
Belmont Global Advisors sold 80,000 ChemoCentryx, Inc. shares in Q3 2016, an estimated $359K.
Belmont Global Advisors first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 5 quarters.
Belmont Global Advisors's ChemoCentryx, Inc. position peaked at $1.16M in Q1 2014.
72 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2016.

Based on Belmont Global Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.